Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06212791 · ClinicalTrials.gov registry record
EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation
A clinical trial of Paroxysmal Atrial Fibrillation, sponsored by Virginia Commonwealth University.
- Recruiting
- Registry status
- 50
- Enrollment target
- 1
- Study location
NCT06212791: Recruiting study of Paroxysmal Atrial Fibrillation, sponsored by Virginia Commonwealth University.
NCT06212791 is a study of Paroxysmal Atrial Fibrillation that is actively recruiting participants, run by Virginia Commonwealth University. The registered enrollment target is 50 participants, below the 857-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06212791, a study of Paroxysmal Atrial Fibrillation, is actively recruiting participants, sponsored by Virginia Commonwealth University.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 1
- Study location
Study Summary
Longitudinal, observational cohort study to evaluate changes in left atrial (LA) reservoir function during exercise and overall exertional capacity in patients following catheter ablation for paroxysmal atrial fibrillation (AF).
Primary Outcome
Change in LA reservoir volume reserve from baseline to follow up, change in left ventricular (LV) stroke volume reserve from baseline to follow up, correlation between changes in LA reservoir volume reserve and changes in LV stroke volume reserve. Therefore the follow up testing will be performed 5-6 months (to be more specific: 150-180 days) after catheter ablation.
Conditions Studied
Interventions
- BEHAVIORAL Self- Report Evaluation-Duke Activity Status Index
- BEHAVIORAL Self- Report Evaluation Atrial Fibrillation Effect on Quality of Life Questionnaire
- DIAGNOSTIC_TEST Cardiopulmonary exercise test (CPET)
- DIAGNOSTIC_TEST Transthoracic echocardiogram
- DIAGNOSTIC_TEST Ambulatory cardiac rhythm assessment
Study Locations (1)
Virginia
- Virginia Commonwealth University - Richmond
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2024-12-26 |
| Est. Completion | 2028-03 |
What NCT06212791 shows while recruiting
NCT06212791 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 857-participant average among 24 other Paroxysmal Atrial Fibrillation trials with a reported enrollment target (94% lower).
The record links to 1 condition, with Paroxysmal Atrial Fibrillation appearing as the primary indexed condition, and to 5 interventions - of which Self- Report Evaluation-Duke Activity Status Index is the first listed.
NCT06212791 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT06212791 about?
NCT06212791 is a clinical study titled "EXercise Cardiac Magnetic Resonance Assessment of Left Atrial Mechanics Following Ablation". Longitudinal, observational cohort study to evaluate changes in left atrial (LA) reservoir function during exercise and overall exertional capacity in patients following catheter ablation for paroxysmal atrial fibrillation (AF).
What is the current status of trial NCT06212791?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2024-12-26. Estimated completion is 2028-03.
What conditions does trial NCT06212791 study?
This clinical trial studies the following conditions: Paroxysmal Atrial Fibrillation.
What interventions are being tested in trial NCT06212791?
The interventions under investigation include: Self- Report Evaluation-Duke Activity Status Index (BEHAVIORAL), Self- Report Evaluation Atrial Fibrillation Effect on Quality of Life Questionnaire (BEHAVIORAL), Cardiopulmonary exercise test (CPET) (DIAGNOSTIC_TEST), Transthoracic echocardiogram (DIAGNOSTIC_TEST), Ambulatory cardiac rhythm assessment (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06212791?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06212791 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Paroxysmal Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06212791's enrollment target sits among peer trials
50 22nd of 24 higher than 1 of 24 other Paroxysmal Atrial Fibrillation trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Paroxysmal Atrial Fibrillation trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ULTRA-HFIB-Redo: Ultrasound-based Renal Sympathetic Denervation vs Control in Redo Ablation Patients
RECRUITING · NA
-
Determinates of Atrial Tracking and Prevalence of Atrial Fibrillation in the Micra AV2 (DANCE AFIB)
RECRUITING
-
STOP AF First Post-Approval Study
RECRUITING
-
The Long-term Safety and Effectiveness Evaluation of the QDOT MICRO System Use in Conjunction With VISITAG SURPOINT Module for the Treatment of Symptomatic Drug Refractory Paroxysmal Atrial Fibrillation.
RECRUITING
-
Biomarker-Guided Optimization of Transcutaneous Vagal Stimulation for Atrial (BiG tVNS-AF)
RECRUITING · NA
-
Pragmatic Evaluation of a Pentaspline Pulsed Field Ablation System to Treat Atrial Fibrillation and Related Arrhythmias
RECRUITING · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI